| Literature DB >> 35492565 |
Jannatun Nesa1, Abdul Sadat2, Danieli F Buccini3, Ahmet Kati4,5, Amit K Mandal1,6, Octavio L Franco3,7.
Abstract
Bombyx mori L., a primary producer of silk, is the main tool in the sericulture industry and provides the means of livelihood to a large number of people. Silk cocoon crop losses due to bacterial infection pose a major threat to the sericulture industry. Bombyx mori L., a silkworm of the mulberry type, has a sophisticated inherent innate immune mechanism to combat such invasive pathogens. Among all the components in this defense system, antimicrobial peptides (AMPs) are notable due to their specificity towards the invading pathogens without harming the normal host cells. Bombyx mori L. so far has had AMPs identified that belong to six different families, namely cecropin, defensin, moricin, gloverin, attacin and lebocin, which are produced by the Toll and immune deficiency (IMD) pathways. Their diverse modes of action depend on microbial pathogens and are still under investigation. This review examines the recent progress in understanding the immune defense mechanism of Bombyx mori based on AMPs. This journal is © The Royal Society of Chemistry.Entities:
Year: 2020 PMID: 35492565 PMCID: PMC9047522 DOI: 10.1039/c9ra06864c
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Microbial diseases of mulberry silkworm, B. Mori[2–4]
| Sl. no. | Disease | Pathogen | Season | Prevalence in India | Symptoms | % loss of cocoons (2016-17) |
|---|---|---|---|---|---|---|
| 1. | Viral | |||||
| Nuclear polyhedrosis | BmNPV | Summer and rainy season | Prevalent | Swelling on inter-segmental region, shining and fragile skin, milky white fluid | 20 | |
| Cytoplasmic polyhedrosis | BmCPV | Prevalent | Translucent cephalo-thoracic region; diarrhoea; retarded growth; milky white midgut; whitish faeces | |||
| Infectious flacherie | BmIFV | Prevalent | Translucent cephalothoraxes; retarded growth; vomiting and diarrhoea | |||
| Densonucleosis | BmDNV1, BmDNV2, BmDNV3 | Prevalent not reported, not reported | Translucent cephalothoraxes; retarded growth; vomiting and diarrhoea. | |||
| 2. | Bacteraemia | |||||
| Bacterial diseases of digestive tract |
| Summer and rainy season | Prevalent | Sluggish movement; retarded growth; transparent cephalo-thoracic region | 30 | |
| Septicaemia |
| Prevalent | Sluggish movement low appetite; swollen thorax; shrinkage; vomiting softening and discoloured body | |||
| Toxicosis |
| Prevalent | Sluggish movement; retarded growth; cessation of feeding; vomiting; paralysis and death; corpse stretched and cephalo-thoracic region bent like hook | |||
| 3. | Mycosis | |||||
| White muscardine |
| Rainy season | Prevalent | Oily specks on the body surface; larva on death softens, turns hard and later mummifies; mummified larvae appear white | 10 | |
| Green muscardine |
| Prevalent | Large specks with black periphery; mummified larvae green in colour | |||
| Yellow muscardine |
| Not reported | Large disease specks around stigma and small on skin, mummified larvae yellow | |||
| Red muscardine |
| Not reported | Develop red patches few hour before death; no external growth | |||
| Orange muscardine |
| Not reported | Develop orange patches few hour before death; no external growth | |||
| Aspergillosis |
| Prevalent | Formation of light yellow coloured spores on surface with dirty brown | |||
| 4. | Protozoan | |||||
| Pebrine |
| All season | Prevalent | Sluggish larvae with paler, translucent, wrinkled skin | 40 | |
|
| Prevalent | |||||
|
| Not reported | |||||
|
| Prevalent | |||||
|
| Not reported | |||||
|
| Not reported | |||||
|
| Not reported | |||||
|
| Not reported | |||||
|
| Not reported | |||||
Fig. 1Relative abundance of different bacterial phyla in host samples (this figure has been adapted from Chen et al., 2018 with permission from Springer Nature).[12]
Major families of antimicrobial peptides of B. mori[20,21,31,35,38,40,42,47]
| Antimicrobial Peptide | Amino acid sequence of peptide | Activity | Target | Mode of action |
|---|---|---|---|---|
| Cecropin A1 | MNFVRILSFVFALVLALGAVSAAPEPRWKLFKKIEKVGRNVRDGLIKAGPAIAVIGQAKSLGK | Antimicrobial and cytotoxicity | Bacterial and human leukemic cell | Form continuous leaky pore on plasma membrane |
| Cecropin B6 | MNFAKILSFVFALVLALSMTSAAPEPRWKIFKKIEKMGRNIRDGIVKAGPAIEVLGSAKAIGK | |||
| Cecropin C | RWKLFKKIEKVGRNVRDGLIKAGPAIAVIGQAKSL | |||
| Cecropin D | MKISKIFVFVFAIVFATASVSAAPGNFFKDLVSIVLDVSGS | |||
| Cecropin E | MNFSRALFYVFAVFLVCASVMAAPEPRWKIFKKIEKVGQNIRDGIIKAGPAVAVVGQAATIAHGK | |||
| Defensin | MAHQRKSLVIFIFLTVLVFVFALPRDATVFDNQHSEVAIEKSTSKIDSSDVKIPGRIWCEFEEATETAIC | Antimicrobial | Bacteria and fungi | Disrupt bacterial cell membrane. |
| QEHCLPKGYSYGICVSNTCSCI | Hamper cell wall biosynthesis in fungi | |||
| Bmmor | MNILKLFFVFIVAMSLVSCSTAAPAKIPIKAIKTVGKAVGKGLRAINIASTANDVFNFLKPKKRKH | Antimicrobial | Specially gram-positive bacteria and fungi | Increase membrane permeability in target organism |
| Moricin Like A | AKIPIKAIKTVGKAVGKGLRAINIASTANDVFNFLKPKKRKA | |||
| Moricin Like B | MKVFSFFCVVLAMLVLIMGGTSAAPEPKGIGKIIRKGGKVIKHGLTAIGVGAAGHEVYQDSKNSG | |||
| Gloverin1 | MYSKVLLSAALLVCVNAQVSMPPGYAEKYPITSQFSRSVRHPRDIHDFVTWDREMGGGKVFGTLGESDQGLFGKGGYNREFFNDDRGKLTGQAYGTRVLGPGGDSTSYGGRLDWANENAKAAIDLNRQIGGSAGIEASAS | Antimicrobial | Strongly effective against broad spectrum bacteria and viruses. But less effective against yeasts. | Increase membrane permeability in target organism and intra-cellular killing by altering cellular functions |
| GVWDLGKNTHLSAGGVVSKEFGHRRPDVGLQAQITHEW | ||||
| Gloverin2 | MNTNLFYIFATTLVCVNAEVYGPSDYAEDYSISGQSSRRHPRDVTWDKQMGGGKVFGTLGQNDDGLFGKAGYNREIFNDDRGKLTGQAYGTRVLGPGGDSTNYGGRLDWANKNAQATIDLNRQIGGRSGMTASGSGVWDL | |||
| DKNTHFSAGGMVSKEFGHKRPDVGLQAEIRHDW | ||||
| Gloverin3 | MNSKLLFFIATVLVCVNAEVYRSPDYEEEYPIRGLFSKRHPRDVTWDTKMGGGKVFGTLGQNDDGLFGKAGYNREIFNDDRGQLTGQAYGTRVLGPGGDSTNYGGRLDWANKNAQAAIDINRQIGGRSGMTASGSGVWDL | |||
| DKNTHISAGGMVSKEFGHRRPDVGLQAEIRHEW | ||||
| Gloverin4 | MNSKLLYFFATVLVCVNAEVYWEDEEGYPVSGQFSKRHPRDVTWDKQVGGGKVFGTLGQNDDGLFGKAGYNREIFNDDRGKLTGQAYGTRVLGPAGDSTNYGGRLDWANKNAEAAIDINRQIGGRSGMTATGSGVWDLDK | |||
| NTRLSAGGMVSKEFGHRRPDVGVQAEFRHDW | ||||
| Attacin | MSKSVALLLLCACLASGRHVPTRARRQAGSFTVNSDGTSGAALKVPLTGNDKNVLSAIGSADFNDRHKLS | Antimicrobial | Strongly effective against broad spectrum bacteria | Rather than acting on cell wall, attacin hampers plasma membrane synthesis in growing bacterial cell |
| AASAGLALDNVNGHGLSLTGTRIPGFGEQLGVAGKVNLFHNNNHDLSAKAFAIRNSPSAFPNAPNFNTLG | ||||
| GGLDYMFKQKVGASLSAAHSDVINRNDYSAGGKLNLFRSPSSSLDFNAGFKKFDTPFYRSSWEPNVGFSF | ||||
| SKFF | ||||
| Lebocin 1 | DLRFLYPRGKLPVPTPPPFNPKPIYIDMGNRY | Antimicrobial | Bacteria | Form leakage in lipid bilayer of the plasma membrane and showed synergistic effect on cecropin D |
| Lebocin 2 | DLRFLYPRGKLPVPTPPPFNPKPIYIDMGNRY | |||
| Lebocin 3 | DLRFLYPRGKLPVPTPPPFNPKPIYIDMGNRY | |||
| Lebocin 4 | DLRFLYPRGKLPVPTPPPFNPKPIYIDMGNRY |
Bacterial inhibition of antimicrobial peptides against Gram +ve and Gram −ve bacteria with special emphasis on Cecropin, Moricin, Gloverin paralogs[20]a
| Gram-positive bacteria | Gram-negative bacteria | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| Ralstonia |
| |
| BmcecA1 | + | − | + | − | − | − | + | + | + | − |
| BmcecB6 | + | + | + | + | − | + | + | + | + | − |
| BmcecC | − | − | − | − | − | − | − | − | − | − |
| BmcecD | + | + | + | + | − | + | + | + | + | − |
| BmcecE | − | − | + | − | − | + | + | + | + | − |
| Bmmor | + | + | + | + | + | + | + | + | + | − |
| BmmorLA | + | + | − | − | + | − | + | − | + | − |
| BmmorLB | − | − | − | − | − | − | − | − | − | − |
| Bmglv1 | − | − | + | + | − | + | + | + | + | + |
| Bmglv2 | − | − | + | + | − | + | + | + | + | + |
| Bmglv3 | − | − | + | + | − | + | + | + | + | + |
| Bmglv4 | − | − | + | + | − | + | + | + | + | + |
N. B. “+” active, “−” inactive.
Fig. 2Signalling pathway of antimicrobial activity achieved by AMPs in B. mori. GNBP-3 recognize β-1,3-glucan present on the cell wall of the invading fungi that activate Toll pathway through Toll9, using serine protease cascade, and persuade production of the AMPs that kill invading pathogens. On the other hand, invading Gram-positive bacteria produce Lys-PG, which also activates expression of AMPs via Toll9 using serine protease cascade. PGRPs recognise PGs of the Gram-positive and Gram-negative bacterial cell wall to induce AMP production through IMD pathway. PGRP-L6 in B. mori may act as intracellular receptors that control IMD pathway. GNBP: Gram-Negative Binding protein, PSH: persephone, SP: serine protease, SPE: Spatzle-processing enzyme, pro Spz: pro Spatzle, Spz: Spatzle, PG: peptidoglycan, Lys-PG: Lysis-PG, PGRP: peptidoglycan recognition protein, IMD: immune deficiency, DAP-PG: diaminopimelic acid-PGs, AMPs: antimicrobial peptides.[52–65]